Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment
Interferon beta is a safe and efficacious treatment for relapsing multiple sclerosis (MS). However, there is some evidence that uric acid, a scavenger of peroxynitrite, is involved in MS pathology and that increasing serum uric acid levels might have beneficial therapeutic effects. The aim of this s...
Main Authors: | Toncev Gordana, Vesic Katarina, Aleksic Dejan, Lazarevic Snežana |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-10-01
|
Series: | Serbian Journal of Experimental and Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1515/sjecr-2016-0052 |
Similar Items
-
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
by: Elmazny A, et al.
Published: (2020-03-01) -
Therapeutic value of serum uric acid levels increasing in the treatment of multiple sclerosis
by: Tončev Goran
Published: (2006-01-01) -
Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01) -
Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
by: Ivanović Jovana, et al.
Published: (2019-01-01) -
Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01)